Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial CTSU-A031102
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy using Paclitaxel, Ifosfamide, and Cisplatin (TIP) with High-Dose Chemotherapy using Mobilizing Paclitaxel plus Ifosfamide followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Type:
Treatment
Phase:
Phase III
Status:
Closed to Accrual with Ongoing Follow-up
Treatments:
Chemotherapy: Systemic
Randomized:
Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
James Hu, M.D.
Other Trial Staff:
Cheryl Kefauver, Coordinator, Aleksei Belousov, D.M., Lagrimas Ilagan, D.M., Shamim Jhimlee, Coordinator, Taison Tran, Coordinator, Charis Barg, Coordinator, Bartolo Santos, Coordinator
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.